Total Payments
$11,207
2024 Payments
$1,366
Companies
54
Transactions
704
Medicare Patients
17,711
Medicare Billing
$2.1M
Payment Breakdown by Category
Food & Beverage$11,093 (99.0%)
Education$113.38 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,093 | 697 | 99.0% |
| Education | $113.38 | 7 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,662 | 130 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,208 | 77 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,039 | 74 | $0 (2024) |
| ABBVIE INC. | $976.45 | 57 | $0 (2024) |
| Lilly USA, LLC | $727.20 | 47 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $632.36 | 41 | $0 (2022) |
| PFIZER INC. | $529.50 | 47 | $0 (2024) |
| Amgen Inc. | $520.59 | 31 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $432.98 | 26 | $0 (2022) |
| Merck Sharp & Dohme LLC | $282.14 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,366 | 70 | ABBVIE INC. ($331.67) |
| 2023 | $1,499 | 73 | Novo Nordisk Inc ($209.26) |
| 2022 | $1,321 | 70 | Novo Nordisk Inc ($236.40) |
| 2021 | $1,146 | 68 | Novo Nordisk Inc ($214.43) |
| 2020 | $989.66 | 66 | AstraZeneca Pharmaceuticals LP ($170.21) |
| 2019 | $1,485 | 107 | AstraZeneca Pharmaceuticals LP ($306.37) |
| 2018 | $1,863 | 137 | Novo Nordisk Inc ($312.15) |
| 2017 | $1,537 | 113 | GlaxoSmithKline, LLC. ($193.54) |
All Payment Transactions
704 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $41.69 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: UROLOGY | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $0.97 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: PAIN | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Inflammation | ||||||
| 11/11/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.59 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $13.78 | General |
| Category: Allergy/Immunology | ||||||
| 10/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Biological | ||||||
| 09/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.35 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.67 | General |
| 08/30/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: VACCINES | ||||||
| 08/28/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Diabetes Care | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 5,332 | 11,204 | $1.8M | $675,975 |
| 2022 | 29 | 4,920 | 8,477 | $1.5M | $591,848 |
| 2021 | 26 | 3,855 | 6,894 | $1.2M | $480,739 |
| 2020 | 28 | 3,604 | 6,413 | $1.0M | $385,893 |
Total Patients
17,711
Total Services
32,988
Medicare Billing
$2.1M
Procedure Codes
119
All Medicare Procedures & Services
119 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 799 | 3,581 | $898,830 | $313,369 | 34.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 656 | 656 | $167,909 | $82,479 | 49.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 273 | 421 | $149,876 | $56,729 | 37.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 185 | 1,113 | $139,125 | $53,542 | 38.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 115 | 126 | $58,562 | $27,023 | 46.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 137 | 720 | $74,160 | $26,529 | 35.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 143 | 660 | $64,020 | $24,662 | 38.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 212 | 217 | $36,239 | $15,438 | 42.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 717 | 718 | $26,548 | $12,691 | 47.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 669 | 669 | $24,084 | $11,841 | 49.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 99 | 190 | $17,860 | $6,831 | 38.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 35 | 42 | $14,172 | $6,359 | 44.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 39 | 39 | $17,082 | $5,578 | 32.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 29 | 29 | $9,541 | $4,684 | 49.1% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 53 | 149 | $11,920 | $4,474 | 37.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 24 | 24 | $7,896 | $3,777 | 47.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 226 | 346 | $9,688 | $3,644 | 37.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 50 | $8,950 | $3,003 | 33.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 67 | 128 | $5,760 | $1,958 | 34.0% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2023 | 141 | 196 | $3,920 | $1,858 | 47.4% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 131 | 131 | $4,716 | $1,842 | 39.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 127 | 133 | $3,857 | $1,389 | 36.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 22 | 24 | $3,120 | $1,252 | 40.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $4,884 | $1,165 | 23.9% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2023 | 15 | 15 | $2,820 | $1,084 | 38.4% |
About Dr. Shazia Nasir, MD
Dr. Shazia Nasir, MD is a Internal Medicine healthcare provider based in Clermont, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538256953.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shazia Nasir, MD has received a total of $11,207 in payments from pharmaceutical and medical device companies, with $1,366 received in 2024. These payments were reported across 704 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($11,093).
As a Medicare-enrolled provider, Nasir has provided services to 17,711 Medicare beneficiaries, totaling 32,988 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 119 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Clermont, FL
- Active Since 10/06/2006
- Last Updated 10/14/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1538256953
Products in Payments
- Ozempic (Drug) $908.46
- FARXIGA (Drug) $703.00
- TRELEGY ELLIPTA (Drug) $385.38
- BREO (Drug) $335.47
- INVOKANA (Drug) $325.80
- UBRELVY (Drug) $313.52
- XARELTO (Drug) $306.56
- QULIPTA (Drug) $305.79
- CHANTIX (Drug) $255.74
- GEMTESA (Drug) $243.07
- EMGALITY (Drug) $236.91
- Rybelsus (Drug) $236.56
- ENTRESTO (Drug) $222.86
- SOLIQUA 100/33 (Biological) $220.34
- Kerendia (Drug) $205.65
- JARDIANCE (Drug) $197.35
- MOUNJARO (Drug) $175.98
- LINZESS (Drug) $169.75
- Puraply (Medical Supply) $168.33
- Otezla (Drug) $156.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Clermont
Sumith Aleti, Md, MD
Internal Medicine — Payments: $29,143
Internal Medicine $29,143
Alexander Bolanos, M.d, M.D
Internal Medicine — Payments: $15,769
Internal Medicine $15,769
Nathan Bibliowicz, Do, DO
Internal Medicine — Payments: $14,320
Internal Medicine $14,320
Carolina Mejia Otero, M.d, M.D
Internal Medicine — Payments: $7,926
Internal Medicine $7,926
Dr. Kiran Mogali, M.d, M.D
Internal Medicine — Payments: $7,620
Internal Medicine $7,620
Dr. Paramita Ghosh, Md, MD
Internal Medicine — Payments: $6,937
Internal Medicine $6,937